We've had our Eyes On some of the latest Pharmaceutical news including approvals, partnering, mergers, research programs, and

News & Views - sharing some oncology, AZD, M&A tidbits that caught our eye.

his week we've been looking at the competition heating up due to a combination of M&A, biosimilar entrants, and new clinical data ...

We've had our Eyes On recent data releases, commercial strategy updates, and some FDA updates. What caught your Eye last week?

The ASCO 2024 annual meeting took place from 31st May to 4th June. A number of firms presented data, and others used this as an opportunity

Check out this Top Drugs of 2023 list with links to interesting reports in PharmaTell Studio. Contact us for a trial.